Glucagon receptor
The third target in triple-agonist compounds.
Glucagon raises blood sugar and increases energy expenditure. Adding glucagon activity to GLP-1 and GIP activity is the design idea behind retatrutide, which remains investigational.
The third target in triple-agonist compounds.
Glucagon raises blood sugar and increases energy expenditure. Adding glucagon activity to GLP-1 and GIP activity is the design idea behind retatrutide, which remains investigational.